Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | CES2 | O00748 | 1/20 | 0.43 |
| ▸ | CES1 | P23141 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 3/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.40 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.40 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CASP1 | P29466 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28983970 | 0.93 | KDM4E (0.46) | SMN1; SMN2KDM4EKDM4CKMT2ACES2 | |
| SCHEMBL1258860 | 0.82 | HPGD (0.50) | SMN1; SMN2KDM4EALDH1A1NPC1RAB9A | |
| SCHEMBL5124451 | 0.82 | SMN1; SMN2 (0.52) | SMN1; SMN2KDM4EKDM4CKMT2AALDH1A1 | |
| SCHEMBL12191262 | 0.79 | — | — | |
| SCHEMBL9547521 | 0.79 | SMN1; SMN2 (0.56) | SMN1; SMN2KDM4CKMT2ACES2CES1 | |
| SCHEMBL3483318 | 0.77 | — | — | |
| SCHEMBL28883729 | 0.75 | SMN1; SMN2 (0.43) | SMN1; SMN2KDM4EKDM4CALDH1A1NPC1 | |
| SCHEMBL11765049 | 0.75 | — | — | |
| SCHEMBL12822285 | 0.74 | RAB9A (0.57) | SMN1; SMN2KDM4CKMT2AALDH1A1NPC1 | |
| SCHEMBL29364207 | 0.74 | SMN1; SMN2 (0.49) | SMN1; SMN2KDM4CKMT2ACES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118126441-A | Damping EVA foaming material for picocell racket | 合肥市尚技体育用品有限公司 | 2024-06-04 | — | — | CN | claimed |
| CN-109898342-B | Preparation method of scratch-resistant synthetic leather based on high-resilience waterborne polyurethane | 四川大学 | 2021-08-27 | — | — | CN | claimed |
| CN-105209449-B | Inhibitors of the kynurenine pathway | 库拉德夫制药私人有限公司 | 2019-02-01 | — | — | CN | claimed |
| CN-119056460-A | Method for catalytic synthesis of bio-based furfuryl carbamate | 丽水学院 | 2024-12-03 | — | — | CN | disclosed |
| CN-110105434-B | Stapled and stitched polypeptides and uses thereof | 哈佛大学的校长及成员们 | 2024-09-17 | — | — | CN | disclosed |
| CN-113710660-B | DOT1L degradation agent and application thereof | 达纳-法伯癌症研究公司 | 2024-07-02 | — | — | CN | disclosed |
| CN-114736219-B | Antitumor compounds | 法马马有限公司 | 2024-06-07 | — | — | CN | disclosed |
| CN-114751920-B | Antitumor compounds | 法马马有限公司 | 2024-06-07 | — | — | CN | disclosed |
| CN-118126441-A | Damping EVA foaming material for picocell racket | 合肥市尚技体育用品有限公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-118076584-A | Esters of retinoids and bakuchiol and formulations thereof | 康纳根有限公司 | 2024-05-24 | — | — | CN | disclosed |
| CN-118059096-A | Methods of treating CNS disorders | 杭州高光制药有限公司 | 2024-05-24 | — | — | CN | disclosed |
| EP-2513200-A1 | A BIOMATERIAL | Vysera Biomedical Limited (IE) | 2012-10-24 | — | — | EP | disclosed |
| EP-2512386-A1 | A GASTROINTESTINAL IMPLANT DEVICE | Vysera Biomedical Limited (IE) | 2012-10-24 | — | — | EP | disclosed |
| CN-102711473-A | Bruton's tyrosine kinase inhibitors | BIOGEN IDEC INC | 2012-10-03 | — | — | CN | disclosed |
| CN-102159203-A | Activation of histone deacetylase 1(HDAC1) protects against DNA damage and increases neuronal survival | MASSACHUSETTS INST TECHNOLOGY | 2011-08-17 | — | — | CN | disclosed |
| WO-2011073970-A1 | A GASTROINTESTINAL IMPLANT DEVICE | VYSERA BIOMEDICAL LIMITED (IE) | 2011-06-23 | — | — | WO | disclosed |
| WO-2011073967-A1 | A BIOMATERIAL | VYSERA BIOMEDICAL LIMITED (IE) | 2011-06-23 | — | — | WO | disclosed |
| CN-101932592-A | Antineoplastic compound | PHARMA MAR SA | 2010-12-29 | — | — | CN | disclosed |
| CN-101547689-A | Tetra-substituted NDGA derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use | ERIMOS PHARMACEUTICALS LLC (US) | 2009-09-30 | — | — | CN | disclosed |
| CN-101010336-A | Peptide antibiotics and process for preparing same | BIOSOURCE PHARM INC (US) | 2007-08-01 | — | — | CN | disclosed |